✷ Report Code: A01044 | Pages: 180 | Mar 2022 | 13997 Views | ||
Author(s) : Linu D, Tanjeem S , Onkar S | Tables: 142 | Charts: 57 |
|
The COVID-19 outbreak negatively impacted growth of the global biosurgery market. The COVID-19 pandemic stressed healthcare systems across the globe. The soft tissue orthopaedic and urogynecology procedure is profoundly affected by the COVID-19 pandemic. A number of clinics and hospitals were restructured to increase hospital capacities for patients diagnosed with COVID-19. Implementation of lockdown, owing to the COVID-19 outbreak resulted in decline in number of patient visits for other diseases, such as cancer and diabetes, during the pandemic. For instance, in 2021, Tissue Regenix Group, a medical technology company, reported that approximately 22% of biosurgery revenue decreased due to cancellation of elective surgical procedures.
The global biosurgery market size is expected to increase substantially in the near future, owing to high investment by governments and private organizations in the medical device sector, increase in spending on R&D activities by researchers, and aggressive strategies adopted by top players such as new product launches. Growth of the global biosurgery market share is majorly driven by increase in prevalence of chronic disease, rise in demand for elective surgeries, increase in funding from private & government organizations for development of healthcare infrastructure, and increase in number of geriatric population.Â
Increase in prevalence of severe traumatic injuries drives the growth of the biosurgery market share, as the rise in number of traumatic injuries increases the demand for biosurgery products.Â
In addition, presence of key manufacturing companies to manufacture advanced biosurgery products contributes toward the biosurgery market growth. Moreover, increase in prevalence of geriatric population, who are more susceptible to chronic diseases, propels growth of the biosurgery market opportunity.Â
Furthermore, advancement in R&D activities in pharmaceutical sector and development of medical device sector is expected to provide lucrative opportunities for expansion of the global biosurgery market during the forecast period. Moreover, increase in number of surgical procedures and rise in number of sports-related injuries propel the growth of the biosurgery industry.
Initiatives taken by government and private organizations to develop the medical device industry drive the growth of the biosurgery industry. However, high cost of biosurgery products and stringent regulations are expected to restrict the market growth during the biosurgery market forecast.
GLOBAL BIOSURGICAL MARKET SEGMENTATION
The biosurgery market size is segmented into product type, application, source, and region. Depending on product type, the market is divided into anti-adhesive agents, hemostatic agents and surgical sealants, bone graft substitutes, and mesh (soft tissue management). On the basis of application, the market is segmented into cardiovascular and thoracic, neuro and spine surgery, orthopedic surgery, and general surgery. On the basis of source, the market is segmented into biologics products and synthetic products.
Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Segment Review
Depending on product type, the bone graft substitutes segment was the highest contributor to the market in 2020, and this trend is expected to continue during the forecast period, due to surge in demand for bone graft substituent products and increase in number of sports injuries and surgeries.
However, the anti-adhesive agents segment is expected to witness considerable growth during the forecast period, owing to increase in incidence of surgeries, such as cardiovascular surgery and general abdominal surgery, which surge the need for anti-adhesive agents in the biosurgery market.
By application, the neuro and spine surgery segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in prevalence of neurological disorder.Â
However, the general surgery segment is expected to witness considerable growth during the forecast period, owing to increase in incidence of surgeries, rise in sedentary lifestyle, and increase in geriatric population.
On the basis of source, the biologics products segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in demand for natural products and rise in technological development in the pharmaceutical sector.
However, the synthetic products segment is expected to witness considerable growth during the forecast period, owing to advancement in R&D activities for manufacturing of various products for the surgery.
North America dominated the biosurgery market in 2020, and is expected to be dominant during the forecast period, owing to rise in prevalence of chronic disease, increase in number of surgery, presence of key players for manufacturing biosurgery products, and rise in development in R&D activities in the healthcare sector. However, Asia-Pacific is expected to register highest CAGR of 10.2% from 2021 to 2030, owing to increase in number of geriatric population, rise in number of sport related surgery and injury, and increase in demand for biosurgery products.Â
The major companies profiled in this report include, Aroa Biosurgery Limited,   B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Hemostasis LLC, Integra LifeSciences Holdings Corp., Johnson and Johnson, Medtronic PLC, Sanofi S.A., and Tissue Regenix Group.
Biosurgery Market Report Highlights
Aspects | Details |
---|---|
By Product Type |
|
By Application |
|
By Source |
|
By Region |
|
Key Market Players | SANOFI S A, Medtronic, Inc., INTEGRA LIFE SCIENCES HOLDINGS CORP, Baxter International Inc., Becton, Dickinson and Company, JOHNSON and JOHNSON SERVICES, INC., aroa biosurgery limited, HEMOSTASIS LLC, B. BRAUN MELSUNGEN AG, TISSUE REGENIX GROUP |
Loading Table Of Content...
The global biosurgery market is expected to exhibit high growth potential attributable to factors such, as rise in advancements in the medical device sector, increase in prevalence of chronic diseases, and surge in number of surgical procedures. Furthermore, the biosurgery market gains interest in the medical imaging sector, owing to surge in demand for biosurgery product and increase in number of trauma and wound injury. Moreover, increase in number of geriatric population, who are highly prone to chronic diseases, notably contributes toward the growth of the biosurgery market.Â
North America is expected to witness the highest growth in terms of revenue during the forecast period, owing to rise in prevalence of chronic diseases, increase in number of sports-related injuries and surgeries, and strong presence of key players.
Â
A. The total market value of biosurgery market is $11,425.5 million in 2020.
A. The forecast period in the report is from 2021 to 2030
A. The base year for the report is 2020.
A. Yes, biosurgery companies are profiled in the report
A. The top companies that hold the market share in biosurgery market are Aroa Biosurgery Limited, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Hemostasis LLC, Integra LifeSciences Holdings Corp., Johnson and Johnson, Medtronic PLC, Sanofi S.A., and Tissue Regenix Group.
A. The key trends in the biosurgery market are increase in prevalence of chronic disease, rise in demand for elective surgeries, increase in funding from private & government organizations for development of healthcare infrastructure, and increase in number of geriatric population
Start reading instantly.
This Report and over 53,854+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers